Evidence map›Paper›PMID 35378075›Full record

ArticleThe Lancet. Infectious diseases2022

Screening and vaccination against COVID-19 to minimise school closure: a modelling study.

Elisabetta Colosi, Giulia Bassignana, Diego Andrés Contreras, Canelle Poirier, Pierre-Yves Boëlle, Simon Cauchemez, Yazdan Yazdanpanah, Bruno Lina, Arnaud Fontanet, Alain Barrat and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in The Lancet. Infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 2 pooled it
12.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 2 syntheses or guidelines pooled it, 94 citations in OpenAlex.

  1. Pooled it
  2. SARS-CoV-2 Circulation in the School Setting: A Systematic Review and Meta-Analysis.International journal of environmental research and public health · 2022
    Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. The World Café as a Tool for Evaluating the Level of Acceptance of SARS-CoV-2 Screening in School Settings, Puglia Region, Italy, 2023.Health expectations : an international journal of public participation in health care and health policy · 2025
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 2 countries.

Elisabetta ColosiINSERM, Sorbonne Université, Pierre Louis Institute of Epidemiology and Public Health, Paris, France.
Giulia BassignanaINSERM, Sorbonne Université, Pierre Louis Institute of Epidemiology and Public Health, Paris, France.
Diego Andrés ContrerasAix-Marseille Univ, Université de Toulon, CNRS, Centre de Physique Théorique, Turing Center for Living Systems, Marseille, France.
Canelle PoirierINSERM, Sorbonne Université, Pierre Louis Institute of Epidemiology and Public Health, Paris, France.
Pierre-Yves BoëlleINSERM, Sorbonne Université, Pierre Louis Institute of Epidemiology and Public Health, Paris, France.
Simon CauchemezMathematical Modelling of Infectious Diseases Unit, Institut Pasteur, UMR2000, CNRS, Paris, France.
Yazdan YazdanpanahInfection, Antimicrobials, Modelling, Evolution, INSERM, Université de Paris, Paris, France; Bichat Claude Bernard Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
Bruno LinaNational Reference Center for Respiratory Viruses, Department of Virology, Infective Agents Institute, Croix-Rousse Hospital, Hospices Civils de Lyon, Lyon, France; Virpath Laboratory, International Center of Research in Infectiology, INSERM U1111, CNRS-UMR 5308, École Normale Supérieure de Lyon, Université Claude Bernard Lyon, Lyon University, Lyon, France.
Arnaud FontanetEmerging Diseases Epidemiology Unit, Institut Pasteur, Paris, France; PACRI Unit, Conservatoire National des Arts et Metiers, Paris, France.
Alain BarratAix-Marseille Univ, Université de Toulon, CNRS, Centre de Physique Théorique, Turing Center for Living Systems, Marseille, France; Tokyo Tech World Research Hub Initiative, Tokyo Institute of Technology, Tokyo, Japan.
Vittoria ColizzaINSERM, Sorbonne Université, Pierre Louis Institute of Epidemiology and Public Health, Paris, France; Tokyo Tech World Research Hub Initiative, Tokyo Institute of Technology, Tokyo, Japan. Electronic address: vittoria.colizza@inserm.fr.
Inserm · FRTokyo Institute of Technology · JPCentre de Physique Théorique · FRCentre National de la Recherche Scientifique · FRConservatoire National des Arts et Métiers · FRHôpital Bichat-Claude-Bernard · FRSorbonne Université · FRUniversité Claude Bernard Lyon 1 · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSchools were closed extensively in 2020-21 to counter SARS-CoV-2 spread, impacting students' education and wellbeing. With highly contagious variants expanding in Europe, safe options to maintain schools open are urgently needed. By estimating school-specific transmissibility, our study evaluates costs and benefits of different protocols for SARS-CoV-2 control at school.

methodsWe developed an agent-based model of SARS-CoV-2 transmission in schools. We used empirical contact data in a primary and a secondary school and data from pilot screenings in 683 schools during the alpha variant (B.1.1.7) wave in March-June, 2021, in France. We fitted the model to observed school prevalence to estimate the school-specific effective reproductive number for the alpha (R

findingsWe estimated R

interpretationThe COVID-19 pandemic will probably continue to pose a risk to the safe and normal functioning of schools. Extending vaccination coverage in students, complemented by regular testing with good adherence, are essential steps to keep schools open when highly transmissible variants are circulating.

fundingEU Framework Programme for Research and Innovation Horizon 2020, Horizon Europe Framework Programme, Agence Nationale de la Recherche, ANRS-Maladies Infectieuses Émergentes.

Indexed as

COVID-19SARS-CoV-2ChildHumansPandemicsSchoolsVaccination

Identifiers

PMID35378075
PMCPMC8975262
OpenAlexW4223911497

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.